$CALA Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Calithera Biosciences, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Calithera Biosciences, Inc.. Get notifications about new insider transactions in Calithera Biosciences, Inc. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jan 22 2021 | CALA | Calithera Bioscien ... | Sjogren Eric | SR. VP, DRUG DISCOV ... | Option Exercise | A | 2.98 | 125,000 | 372,500 | 125,000 | |
Jan 22 2021 | CALA | Calithera Bioscien ... | Sjogren Eric | SR. VP, DRUG DISCOV ... | Grant | A | 0.00 | 30,000 | 0 | 134,336 | 104.3 K to 134.3 K (+28.75 %) |
Jan 22 2021 | CALA | Calithera Bioscien ... | Sjogren Eric | SR. VP, DRUG DISCOV ... | Grant | A | 0.00 | 30,000 | 0 | 104,336 | 74.3 K to 104.3 K (+40.36 %) |
Jan 22 2021 | CALA | Calithera Bioscien ... | Wong Stephanie | See Remarks | Option Exercise | A | 2.98 | 150,000 | 447,000 | 150,000 | |
Jan 22 2021 | CALA | Calithera Bioscien ... | Wong Stephanie | See Remarks | Grant | A | 0.00 | 30,000 | 0 | 103,156 | 73.2 K to 103.2 K (+41.01 %) |
Jan 22 2021 | CALA | Calithera Bioscien ... | Wong Stephanie | See Remarks | Grant | A | 0.00 | 35,000 | 0 | 73,156 | 38.2 K to 73.2 K (+91.73 %) |
Dec 18 2020 | CALA | Calithera Bioscien ... | Orford Keith | Chief Medical Offic ... | Sell | S | 6.00 | 2,447 | 14,682 | 11,094 | 13.5 K to 11.1 K (-18.07 %) |
Aug 04 2020 | CALA | Calithera Bioscien ... | Garland J. Scott | Director | Option Exercise | A | 4.70 | 40,000 | 188,000 | 40,000 | |
Jun 11 2020 | CALA | Calithera Bioscien ... | George Jean | Director | Option Exercise | A | 5.25 | 20,000 | 105,000 | 20,000 | |
Jun 11 2020 | CALA | Calithera Bioscien ... | JONES SUZY | Director | Option Exercise | A | 5.25 | 20,000 | 105,000 | 20,000 | |
Jun 11 2020 | CALA | Calithera Bioscien ... | Wolff Henry Ward | Director | Option Exercise | A | 5.25 | 20,000 | 105,000 | 20,000 | |
Jun 11 2020 | CALA | Calithera Bioscien ... | Wise Blake | Director | Option Exercise | A | 5.25 | 20,000 | 105,000 | 20,000 | |
Jun 11 2020 | CALA | Calithera Bioscien ... | DRACHMAN JONATHAN G | Director | Option Exercise | A | 5.25 | 20,000 | 105,000 | 20,000 | |
Jun 11 2020 | CALA | Calithera Bioscien ... | PAKIANATHAN DEEPIKA | Director | Option Exercise | A | 5.25 | 20,000 | 105,000 | 20,000 | |
Jun 11 2020 | CALA | Calithera Bioscien ... | AGARWAL SUNIL | Director | Option Exercise | A | 5.25 | 20,000 | 105,000 | 20,000 | |
May 26 2020 | CALA | Calithera Bioscien ... | BVF PARTNERS L P/IL | 10% Owner | Sell | S | 6.00 | 192,250 | 1,153,500 | 480,432 | 672.7 K to 480.4 K (-28.58 %) |
May 26 2020 | CALA | Calithera Bioscien ... | BVF PARTNERS L P/IL | 10% Owner | Sell | S | 6.00 | 1,064,332 | 6,385,992 | 2,766,561 | 3.8 M to 2.8 M (-27.78 %) |
May 26 2020 | CALA | Calithera Bioscien ... | BVF PARTNERS L P/IL | 10% Owner | Sell | S | 6.00 | 1,027,016 | 6,162,096 | 3,712,340 | 4.7 M to 3.7 M (-21.67 %) |
Apr 17 2020 | CALA | Calithera Bioscien ... | Wong Stephanie | SR. VP, FINANCE & S ... | Sell | S | 8.00 | 5,000 | 40,000 | 30,082 | 35.1 K to 30.1 K (-14.25 %) |
Feb 24 2020 | CALA | Calithera Bioscien ... | Orford Keith | Chief Medical Offic ... | Sell | S | 8.00 | 3,021 | 24,168 | 8,541 | 11.6 K to 8.5 K (-26.13 %) |
Jan 22 2020 | CALA | Calithera Bioscien ... | Molineaux Susan | PRESIDENT AND CEO | Option Exercise | A | 7.41 | 400,000 | 2,964,000 | 400,000 | |
Jan 22 2020 | CALA | Calithera Bioscien ... | Wong Stephanie | SR. VP, FINANCE & S ... | Option Exercise | A | 7.41 | 120,000 | 889,200 | 120,000 | |
Jan 22 2020 | CALA | Calithera Bioscien ... | Ray Sumita | See Remarks | Option Exercise | A | 7.41 | 110,000 | 815,100 | 110,000 | |
Jan 22 2020 | CALA | Calithera Bioscien ... | Hecht Curtis | SVP, CHIEF BUSINESS ... | Option Exercise | A | 7.41 | 120,000 | 889,200 | 120,000 | |
Jan 22 2020 | CALA | Calithera Bioscien ... | Molineaux Christopher | SR. VP, DEVELOPMENT | Option Exercise | A | 7.41 | 110,000 | 815,100 | 110,000 | |
Jan 22 2020 | CALA | Calithera Bioscien ... | Orford Keith | Chief Medical Offic ... | Option Exercise | A | 7.41 | 140,000 | 1,037,400 | 140,000 | |
Jan 22 2020 | CALA | Calithera Bioscien ... | Parlati Francesco | VP, RESEARCH | Option Exercise | A | 7.41 | 75,000 | 555,750 | 75,000 | |
Jan 22 2020 | CALA | Calithera Bioscien ... | Sjogren Eric | SR. VP, DRUG DISCOV ... | Option Exercise | A | 7.41 | 110,000 | 815,100 | 110,000 | |
Dec 26 2019 | CALA | Calithera Bioscien ... | Orford Keith | Chief Medical Offic ... | Sell | S | 6.00 | 3,021 | 18,126 | 11,562 | 14.6 K to 11.6 K (-20.72 %) |
Nov 18 2019 | CALA | Calithera Bioscien ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 3.37 | 11,105 | 37,424 | 658,531 | 647.4 K to 658.5 K (+1.72 %) |
Nov 18 2019 | CALA | Calithera Bioscien ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 3.37 | 45,888 | 154,643 | 3,751,608 | 3.7 M to 3.8 M (+1.24 %) |
Nov 18 2019 | CALA | Calithera Bioscien ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 3.37 | 71,495 | 240,938 | 4,640,838 | 4.6 M to 4.6 M (+1.56 %) |
Oct 31 2019 | CALA | Calithera Bioscien ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 2.70 | 57,868 | 156,244 | 647,426 | 589.6 K to 647.4 K (+9.82 %) |
Oct 31 2019 | CALA | Calithera Bioscien ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 2.70 | 331,048 | 893,830 | 3,705,720 | 3.4 M to 3.7 M (+9.81 %) |
Oct 31 2019 | CALA | Calithera Bioscien ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 2.70 | 408,592 | 1,103,198 | 4,569,343 | 4.2 M to 4.6 M (+9.82 %) |
Oct 31 2019 | CALA | Calithera Bioscien ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 2.60 | 116,552 | 303,035 | 589,558 | 473 K to 589.6 K (+24.64 %) |
Oct 31 2019 | CALA | Calithera Bioscien ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 2.60 | 610,052 | 1,586,135 | 3,374,672 | 2.8 M to 3.4 M (+22.07 %) |
Oct 31 2019 | CALA | Calithera Bioscien ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 2.60 | 872,373 | 2,268,170 | 4,160,751 | 3.3 M to 4.2 M (+26.53 %) |
Jun 27 2019 | CALA | Calithera Bioscien ... | Molineaux Christopher | SR. VP, DEVELOPMENT | Buy | P | 3.88 | 51,600 | 200,208 | 457,188 | 405.6 K to 457.2 K (+12.72 %) |
Jun 27 2019 | CALA | Calithera Bioscien ... | Molineaux Susan | PRESIDENT AND CEO | Buy | P | 3.88 | 51,600 | 200,208 | 457,188 | 405.6 K to 457.2 K (+12.72 %) |
Jun 26 2019 | CALA | Calithera Bioscien ... | Sjogren Eric | SR. VP, DRUG DISCOV ... | Option Exercise | M | 0.96 | 21,739 | 20,869 | 0 | |
Jun 26 2019 | CALA | Calithera Bioscien ... | Sjogren Eric | SR. VP, DRUG DISCOV ... | Buy | M | 0.96 | 21,739 | 20,869 | 72,057 | 50.3 K to 72.1 K (+43.20 %) |
Jun 21 2019 | CALA | Calithera Bioscien ... | Wong Stephanie | SR. VP, FINANCE & S ... | Option Exercise | M | 2.64 | 10,000 | 26,400 | 13,284 | |
Jun 21 2019 | CALA | Calithera Bioscien ... | Wong Stephanie | SR. VP, FINANCE & S ... | Buy | M | 2.64 | 10,000 | 26,400 | 31,751 | 21.8 K to 31.8 K (+45.97 %) |
Jun 19 2019 | CALA | Calithera Bioscien ... | Parlati Francesco | VP, RESEARCH | Option Exercise | M | 2.64 | 6,246 | 16,489 | 0 | |
Jun 19 2019 | CALA | Calithera Bioscien ... | Parlati Francesco | VP, RESEARCH | Buy | M | 2.64 | 6,246 | 16,489 | 42,201 | 36 K to 42.2 K (+17.37 %) |
Jun 19 2019 | CALA | Calithera Bioscien ... | Orford Keith | Chief Medical Offic ... | Sell | S | 6.00 | 417 | 2,502 | 12,083 | 12.5 K to 12.1 K (-3.34 %) |
Jun 03 2019 | CALA | Calithera Bioscien ... | Wolff Henry Ward | Director | Option Exercise | A | 5.42 | 11,000 | 59,620 | 11,000 | |
Jun 03 2019 | CALA | Calithera Bioscien ... | PAKIANATHAN DEEPIKA | Director | Option Exercise | A | 5.42 | 11,000 | 59,620 | 11,000 | |
Jun 03 2019 | CALA | Calithera Bioscien ... | DRACHMAN JONATHAN G | Director | Option Exercise | A | 5.42 | 11,000 | 59,620 | 11,000 | |
Jun 03 2019 | CALA | Calithera Bioscien ... | AGARWAL SUNIL | Director | Option Exercise | A | 5.42 | 11,000 | 59,620 | 11,000 | |
Jun 03 2019 | CALA | Calithera Bioscien ... | JONES SUZY | Director | Option Exercise | A | 5.42 | 11,000 | 59,620 | 11,000 | |
Jun 03 2019 | CALA | Calithera Bioscien ... | George Jean | Director | Option Exercise | A | 5.42 | 11,000 | 59,620 | 11,000 | |
Jun 03 2019 | CALA | Calithera Bioscien ... | Wise Blake | Director | Option Exercise | A | 5.42 | 11,000 | 59,620 | 11,000 | |
May 24 2019 | CALA | Calithera Bioscien ... | Orford Keith | Chief Medical Offic ... | Sell | S | 6.00 | 416 | 2,496 | 10,000 | 10.4 K to 10 K (-3.99 %) |
Apr 17 2019 | CALA | Calithera Bioscien ... | Orford Keith | Chief Medical Offic ... | Sell | S | 6.33 | 416 | 2,633 | 10,416 | 10.8 K to 10.4 K (-3.84 %) |
Mar 13 2019 | CALA | Calithera Bioscien ... | Orford Keith | Chief Medical Offic ... | Sell | S | 6.00 | 1,565 | 9,390 | 11,249 | 12.8 K to 11.2 K (-12.21 %) |
Feb 11 2019 | CALA | Calithera Bioscien ... | Molineaux Christopher | SR. VP, DEVELOPMENT | Gift | G | 0.00 | 12,986 | 0 | 395,588 | 408.6 K to 395.6 K (-3.18 %) |
Feb 11 2019 | CALA | Calithera Bioscien ... | Molineaux Susan | PRESIDENT AND CEO | Gift | G | 0.00 | 12,986 | 0 | 395,588 | 408.6 K to 395.6 K (-3.18 %) |
Jan 14 2019 | CALA | Calithera Bioscien ... | Molineaux Christopher | SR. VP, DEVELOPMENT | Option Exercise | A | 4.64 | 105,000 | 487,200 | 105,000 | |
Jan 14 2019 | CALA | Calithera Bioscien ... | Sjogren Eric | SR. VP, DRUG DISCOV ... | Option Exercise | A | 4.64 | 100,000 | 464,000 | 100,000 | |
Jan 14 2019 | CALA | Calithera Bioscien ... | Parlati Francesco | VP, RESEARCH | Option Exercise | A | 4.64 | 47,000 | 218,080 | 47,000 | |
Jan 14 2019 | CALA | Calithera Bioscien ... | Molineaux Susan | PRESIDENT AND CEO | Option Exercise | A | 4.64 | 390,000 | 1,809,600 | 390,000 | |
Jan 14 2019 | CALA | Calithera Bioscien ... | Orford Keith | SR. VP, CHIEF MEDIC ... | Option Exercise | A | 4.64 | 132,000 | 612,480 | 132,000 | |
Jan 14 2019 | CALA | Calithera Bioscien ... | Hecht Curtis | SVP, CHIEF BUSINESS ... | Option Exercise | A | 4.64 | 117,000 | 542,880 | 117,000 | |
Jan 14 2019 | CALA | Calithera Bioscien ... | Wong Stephanie | SR. VP, FINANCE & S ... | Option Exercise | A | 4.64 | 120,000 | 556,800 | 120,000 | |
Jan 14 2019 | CALA | Calithera Bioscien ... | Ray Sumita | See Remarks | Option Exercise | A | 4.64 | 90,000 | 417,600 | 90,000 | |
Nov 16 2018 | CALA | Calithera Bioscien ... | Molineaux Susan | PRESIDENT AND CEO | Gift | G | 0.00 | 6,476 | 0 | 408,574 | 415.1 K to 408.6 K (-1.56 %) |
Nov 16 2018 | CALA | Calithera Bioscien ... | Molineaux Christopher | SR. VP, DEVELOPMENT | Gift | G | 0.00 | 6,476 | 0 | 408,574 | 415.1 K to 408.6 K (-1.56 %) |
Oct 17 2018 | CALA | Calithera Bioscien ... | Orford Keith | SR. VP, CLINICAL DE ... | Sell | S | 6.05 | 313 | 1,894 | 10,314 | 10.6 K to 10.3 K (-2.95 %) |
Oct 15 2018 | CALA | Calithera Bioscien ... | Orford Keith | SR. VP, CLINICAL DE ... | Sell | S | 6.00 | 1,252 | 7,512 | 10,627 | 11.9 K to 10.6 K (-10.54 %) |
Oct 11 2018 | CALA | Calithera Bioscien ... | Ray Sumita | See Remarks | Option Exercise | A | 5.61 | 25,000 | 140,250 | 25,000 | |
Jun 04 2018 | CALA | Calithera Bioscien ... | JONES SUZY | Director | Option Exercise | A | 5.15 | 11,000 | 56,650 | 11,000 | |
Jun 04 2018 | CALA | Calithera Bioscien ... | PAKIANATHAN DEEPIKA | Director | Option Exercise | A | 5.15 | 11,000 | 56,650 | 11,000 | |
Jun 04 2018 | CALA | Calithera Bioscien ... | George Jean | Director | Option Exercise | A | 5.15 | 11,000 | 56,650 | 11,000 | |
Jun 04 2018 | CALA | Calithera Bioscien ... | DRACHMAN JONATHAN G | Director | Option Exercise | A | 5.15 | 11,000 | 56,650 | 11,000 | |
Jun 04 2018 | CALA | Calithera Bioscien ... | Wolff Henry Ward | Director | Option Exercise | A | 5.15 | 11,000 | 56,650 | 11,000 | |
Jun 04 2018 | CALA | Calithera Bioscien ... | Wise Blake | Director | Option Exercise | A | 5.15 | 11,000 | 56,650 | 11,000 | |
Apr 05 2018 | CALA | Calithera Bioscien ... | Sjogren Eric | SR. VP, DRUG DISCOV ... | Option Exercise | M | 0.48 | 8,601 | 4,128 | 0 | |
Apr 05 2018 | CALA | Calithera Bioscien ... | Sjogren Eric | SR. VP, DRUG DISCOV ... | Option Exercise | M | 0.48 | 8,209 | 3,940 | 0 | |
Apr 05 2018 | CALA | Calithera Bioscien ... | Sjogren Eric | SR. VP, DRUG DISCOV ... | Buy | M | 0.48 | 16,810 | 8,069 | 42,818 | 26 K to 42.8 K (+64.63 %) |
Mar 06 2018 | CALA | Calithera Bioscien ... | Molineaux Susan | PRESIDENT AND CEO | Option Exercise | M | 2.64 | 6,798 | 17,947 | 0 | |
Mar 06 2018 | CALA | Calithera Bioscien ... | Molineaux Susan | PRESIDENT AND CEO | Option Exercise | M | 2.64 | 26,992 | 71,259 | 9,729 | |
Mar 06 2018 | CALA | Calithera Bioscien ... | Molineaux Susan | PRESIDENT AND CEO | Buy | M | 2.64 | 26,992 | 71,259 | 44,860 | 17.9 K to 44.9 K (+151.06 %) |
Mar 06 2018 | CALA | Calithera Bioscien ... | Molineaux Christopher | SR. VP, DEVELOPMENT | Option Exercise | M | 2.64 | 26,992 | 71,259 | 9,729 | |
Mar 06 2018 | CALA | Calithera Bioscien ... | Molineaux Christopher | SR. VP, DEVELOPMENT | Option Exercise | M | 2.64 | 6,798 | 17,947 | 0 | |
Mar 06 2018 | CALA | Calithera Bioscien ... | Molineaux Christopher | SR. VP, DEVELOPMENT | Buy | M | 2.64 | 6,798 | 17,947 | 21,000 | 14.2 K to 21 K (+47.87 %) |
Feb 27 2018 | CALA | Calithera Bioscien ... | Wong Stephanie | SR VP, FINANCE AND ... | Option Exercise | M | 2.64 | 10,000 | 26,400 | 21,596 | |
Feb 27 2018 | CALA | Calithera Bioscien ... | Wong Stephanie | SR VP, FINANCE AND ... | Buy | M | 2.64 | 10,000 | 26,400 | 15,000 | 5 K to 15 K (+200.00 %) |
Feb 22 2018 | CALA | Calithera Bioscien ... | Parlati Francesco | VP, RESEARCH | Option Exercise | M | 0.96 | 3,116 | 2,991 | 0 | |
Feb 22 2018 | CALA | Calithera Bioscien ... | Parlati Francesco | VP, RESEARCH | Option Exercise | M | 0.96 | 1,979 | 1,900 | 0 | |
Feb 22 2018 | CALA | Calithera Bioscien ... | Parlati Francesco | VP, RESEARCH | Buy | M | 0.96 | 3,116 | 2,991 | 20,488 | 17.4 K to 20.5 K (+17.94 %) |
Feb 22 2018 | CALA | Calithera Bioscien ... | Parlati Francesco | VP, RESEARCH | Buy | M | 0.96 | 1,979 | 1,900 | 17,372 | 15.4 K to 17.4 K (+12.86 %) |
Jan 16 2018 | CALA | Calithera Bioscien ... | Sjogren Eric | SR. VP, DRUG DISCOV ... | Option Exercise | A | 8.60 | 60,000 | 516,000 | 60,000 | |
Jan 16 2018 | CALA | Calithera Bioscien ... | Wong Stephanie | SR. VP, FINANCE & S ... | Option Exercise | A | 8.60 | 70,000 | 602,000 | 70,000 | |
Jan 16 2018 | CALA | Calithera Bioscien ... | Parlati Francesco | VP, RESEARCH | Option Exercise | A | 8.60 | 30,000 | 258,000 | 30,000 | |
Jan 16 2018 | CALA | Calithera Bioscien ... | Hecht Curtis | SVP, BUS. & CORP. D ... | Option Exercise | A | 8.60 | 70,000 | 602,000 | 70,000 | |
Jan 16 2018 | CALA | Calithera Bioscien ... | Molineaux Susan | PRESIDENT AND CEO | Option Exercise | A | 8.60 | 200,000 | 1,720,000 | 200,000 | |
Jan 16 2018 | CALA | Calithera Bioscien ... | Molineaux Christopher | SR. VP, DEVELOPMENT | Option Exercise | A | 8.60 | 65,000 | 559,000 | 65,000 | |
Jan 16 2018 | CALA | Calithera Bioscien ... | Orford Keith | SR. VP, CLINICAL DE ... | Option Exercise | A | 8.60 | 70,000 | 602,000 | 70,000 | |
Dec 06 2017 | CALA | Calithera Bioscien ... | Molineaux Susan | PRESIDENT AND CEO | Option Exercise | M | 2.64 | 2,700 | 7,128 | 6,006 | |
Dec 06 2017 | CALA | Calithera Bioscien ... | Molineaux Susan | PRESIDENT AND CEO | Option Exercise | M | 0.96 | 6,502 | 6,242 | 0 | |
Dec 06 2017 | CALA | Calithera Bioscien ... | Molineaux Susan | PRESIDENT AND CEO | Option Exercise | M | 2.64 | 5,300 | 13,992 | 34,030 | |
Dec 06 2017 | CALA | Calithera Bioscien ... | Molineaux Susan | PRESIDENT AND CEO | Option Exercise | M | 0.96 | 7,568 | 7,265 | 0 | |
Dec 06 2017 | CALA | Calithera Bioscien ... | Molineaux Susan | PRESIDENT AND CEO | Buy | M | 2.64 | 5,300 | 13,992 | 15,368 | 10.1 K to 15.4 K (+52.64 %) |
Dec 06 2017 | CALA | Calithera Bioscien ... | Molineaux Susan | PRESIDENT AND CEO | Buy | M | 0.96 | 7,568 | 7,265 | 10,068 | 2.5 K to 10.1 K (+302.72 %) |
Dec 06 2017 | CALA | Calithera Bioscien ... | Molineaux Christopher | SR. VP, DEVELOPMENT | Option Exercise | M | 2.64 | 5,300 | 13,992 | 34,030 | |
Dec 06 2017 | CALA | Calithera Bioscien ... | Molineaux Christopher | SR. VP, DEVELOPMENT | Option Exercise | M | 0.96 | 7,568 | 7,265 | 0 | |
Dec 06 2017 | CALA | Calithera Bioscien ... | Molineaux Christopher | SR. VP, DEVELOPMENT | Option Exercise | M | 2.64 | 2,700 | 7,128 | 6,006 | |
Dec 06 2017 | CALA | Calithera Bioscien ... | Molineaux Christopher | SR. VP, DEVELOPMENT | Option Exercise | M | 0.96 | 6,502 | 6,242 | 0 | |
Dec 06 2017 | CALA | Calithera Bioscien ... | Molineaux Christopher | SR. VP, DEVELOPMENT | Buy | M | 2.64 | 2,700 | 7,128 | 11,702 | 9 K to 11.7 K (+29.99 %) |
Dec 06 2017 | CALA | Calithera Bioscien ... | Molineaux Christopher | SR. VP, DEVELOPMENT | Buy | M | 0.96 | 6,502 | 6,242 | 9,002 | 2.5 K to 9 K (+260.08 %) |
Oct 03 2017 | CALA | Calithera Bioscien ... | Wise Blake | Director | Option Exercise | A | 15.75 | 22,000 | 346,500 | 22,000 | |
Oct 03 2017 | CALA | Calithera Bioscien ... | Ray Sumita | See Remarks | Option Exercise | A | 15.75 | 75,000 | 1,181,250 | 75,000 | |
Sep 28 2017 | CALA | Calithera Bioscien ... | ADAGE CAPITAL PARTNERS GP, L.L ... | 10% Owner | Sell | S | 15.50 | 38,000 | 589,000 | 3,546,873 | 3.6 M to 3.5 M (-1.06 %) |
Sep 28 2017 | CALA | Calithera Bioscien ... | ADAGE CAPITAL PARTNERS GP, L.L ... | 10% Owner | Sell | S | 15.59 | 186,000 | 2,899,740 | 3,584,873 | 3.8 M to 3.6 M (-4.93 %) |
Sep 28 2017 | CALA | Calithera Bioscien ... | ADAGE CAPITAL PARTNERS GP, L.L ... | 10% Owner | Sell | S | 15.68 | 352,000 | 5,519,360 | 3,770,873 | 4.1 M to 3.8 M (-8.54 %) |
Jul 19 2017 | CALA | Calithera Bioscien ... | Wong Stephanie | VP, FINANCE AND SEC ... | Sell | S | 18.41 | 3,552 | 65,385 | 10,550 | 14.1 K to 10.6 K (-25.19 %) |
Jul 19 2017 | CALA | Calithera Bioscien ... | Orford Keith | SR. VP, CLINICAL DE ... | Sell | S | 18.31 | 2,120 | 38,823 | 6,879 | 9 K to 6.9 K (-23.56 %) |
Jul 07 2017 | CALA | Calithera Bioscien ... | Hecht Curtis | SVP, BUS. & CORP. D ... | Sell | S | 18.00 | 700 | 12,600 | 15,940 | 16.6 K to 15.9 K (-4.21 %) |
Jun 13 2017 | CALA | Calithera Bioscien ... | PAKIANATHAN DEEPIKA | Director | Option Exercise | A | 14.20 | 11,000 | 156,200 | 11,000 | |
Jun 13 2017 | CALA | Calithera Bioscien ... | DRACHMAN JONATHAN G | Director | Option Exercise | A | 14.20 | 11,000 | 156,200 | 11,000 | |
Jun 13 2017 | CALA | Calithera Bioscien ... | Wolff Henry Ward | Director | Option Exercise | A | 14.20 | 11,000 | 156,200 | 11,000 | |
Jun 13 2017 | CALA | Calithera Bioscien ... | George Jean | Director | Option Exercise | A | 14.20 | 11,000 | 156,200 | 11,000 | |
Jun 13 2017 | CALA | Calithera Bioscien ... | JONES SUZY | Director | Option Exercise | A | 14.20 | 11,000 | 156,200 | 11,000 | |
Jun 13 2017 | CALA | Calithera Bioscien ... | AGARWAL SUNIL | Director | Option Exercise | A | 14.20 | 11,000 | 156,200 | 11,000 | |
May 23 2017 | CALA | Calithera Bioscien ... | Hecht Curtis | SVP, BUS. & CORP. D ... | Sell | S | 16.00 | 650 | 10,400 | 14,910 | 15.6 K to 14.9 K (-4.18 %) |
Mar 24 2017 | CALA | Calithera Bioscien ... | ADAGE CAPITAL PARTNERS GP, L.L ... | 10% Owner | Buy | P | 10.25 | 487,804 | 4,999,991 | 4,122,873 | 3.6 M to 4.1 M (+13.42 %) |
Mar 15 2017 | CALA | Calithera Bioscien ... | Hecht Curtis | SVP, BUS. & CORP. D ... | Sell | S | 14.00 | 600 | 8,400 | 15,560 | 16.2 K to 15.6 K (-3.71 %) |
Mar 06 2017 | CALA | Calithera Bioscien ... | Hecht Curtis | See Remarks | Sell | S | 12.00 | 550 | 6,600 | 16,160 | 16.7 K to 16.2 K (-3.29 %) |
Dec 20 2016 | CALA | Calithera Bioscien ... | Molineaux Susan | PRESIDENT AND CEO | Option Exercise | M | 2.64 | 4,749 | 12,537 | 9,498 | |
Dec 20 2016 | CALA | Calithera Bioscien ... | Molineaux Susan | PRESIDENT AND CEO | Option Exercise | M | 0.96 | 5,418 | 5,201 | 6,502 | |
Dec 20 2016 | CALA | Calithera Bioscien ... | Molineaux Susan | PRESIDENT AND CEO | Option Exercise | M | 2.64 | 15,627 | 41,255 | 42,021 | |
Dec 20 2016 | CALA | Calithera Bioscien ... | Molineaux Susan | PRESIDENT AND CEO | Option Exercise | M | 0.96 | 6,306 | 6,054 | 7,568 | |
Dec 20 2016 | CALA | Calithera Bioscien ... | Molineaux Susan | PRESIDENT AND CEO | Buy | M | 2.64 | 15,627 | 41,255 | 23,810 | 8.2 K to 23.8 K (+190.97 %) |
Dec 20 2016 | CALA | Calithera Bioscien ... | Molineaux Susan | PRESIDENT AND CEO | Buy | M | 0.96 | 6,306 | 6,054 | 8,183 | 1.9 K to 8.2 K (+335.96 %) |
Dec 20 2016 | CALA | Calithera Bioscien ... | Molineaux Christopher | SR. VP, DEVELOPMENT | Option Exercise | M | 2.64 | 15,627 | 41,255 | 42,021 | |
Dec 20 2016 | CALA | Calithera Bioscien ... | Molineaux Christopher | SR. VP, DEVELOPMENT | Option Exercise | M | 0.96 | 6,306 | 6,054 | 7,568 | |
Dec 20 2016 | CALA | Calithera Bioscien ... | Molineaux Christopher | SR. VP, DEVELOPMENT | Option Exercise | M | 2.64 | 4,749 | 12,537 | 9,498 | |
Dec 20 2016 | CALA | Calithera Bioscien ... | Molineaux Christopher | SR. VP, DEVELOPMENT | Option Exercise | M | 0.96 | 5,418 | 5,201 | 6,502 | |
Dec 20 2016 | CALA | Calithera Bioscien ... | Molineaux Christopher | SR. VP, DEVELOPMENT | Buy | M | 2.64 | 4,749 | 12,537 | 12,044 | 7.3 K to 12 K (+65.10 %) |
Dec 20 2016 | CALA | Calithera Bioscien ... | Molineaux Christopher | SR. VP, DEVELOPMENT | Buy | M | 0.96 | 5,418 | 5,201 | 7,295 | 1.9 K to 7.3 K (+288.65 %) |
Dec 01 2016 | CALA | Calithera Bioscien ... | Bennett Mark K | SR. VP, RESEARCH | Option Exercise | A | 3.35 | 56,250 | 188,438 | 56,250 | |
Dec 01 2016 | CALA | Calithera Bioscien ... | Molineaux Christopher | SR. VP, DEVELOPMENT | Option Exercise | A | 3.35 | 75,000 | 251,250 | 75,000 | |
Dec 01 2016 | CALA | Calithera Bioscien ... | Orford Keith | SR. VP, CLINICAL DE ... | Option Exercise | A | 3.35 | 75,000 | 251,250 | 75,000 | |
Dec 01 2016 | CALA | Calithera Bioscien ... | Waddill William D. | SR. VP & CFO | Option Exercise | A | 3.35 | 75,000 | 251,250 | 75,000 | |
Dec 01 2016 | CALA | Calithera Bioscien ... | Sjogren Eric | SR. VP, DRUG DISCOV ... | Option Exercise | A | 3.35 | 75,000 | 251,250 | 75,000 | |
Dec 01 2016 | CALA | Calithera Bioscien ... | Hecht Curtis | VP, BUS. & CORP. DE ... | Option Exercise | A | 3.35 | 75,000 | 251,250 | 75,000 | |
Dec 01 2016 | CALA | Calithera Bioscien ... | Molineaux Susan | PRESIDENT AND CEO | Option Exercise | A | 3.35 | 165,000 | 552,750 | 165,000 | |
Nov 17 2016 | CALA | Calithera Bioscien ... | ADAGE CAPITAL PARTNERS GP, L.L ... | 10% Owner | Buy | P | 3.15 | 500,000 | 1,575,000 | 3,635,069 | 3.1 M to 3.6 M (+15.95 %) |